首页> 外国专利> LYOPHILIZED PREPARATION OF STEM CELL-DERIVED EXOSOMES, AND ANTI-INFLAMMATORY COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT

LYOPHILIZED PREPARATION OF STEM CELL-DERIVED EXOSOMES, AND ANTI-INFLAMMATORY COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT

机译:冻干制备干细胞衍生的外泌体,以及包含与活性成分相同的抗炎组合物

摘要

The present invention provides a lyophilized formulation of stem cell-derived exosomes used for the prevention, suppression, alleviation, amelioration or treatment of inflammation, and an anti-inflammatory composition including the same as an active ingredient. The lyophilized formulation of stem cell-derived exosomes and the anti-inflammatory composition including the same as an active ingredient according to the present invention is able to stabilize stem cell-derived exosomes and exhibit excellent anti-inflammatory effects, and particularly, exhibit remarkable anti-inflammatory effects as compared with not-lyophilized stem cell-derived exosomes isolated and purified from conditioned media of stem cells. Therefore, the lyophilized formulation of stem cell-derived exosomes and the anti-inflammatory composition including the same as an active ingredient is able to effectively prevent, suppress, alleviate, ameliorate or treat inflammatory response or inflammatory diseases.
机译:本发明提供了用于预防,抑制,缓解,改善或治疗炎症的干细胞衍生外泌体的冻干制剂,以及包括与活性成分相同的抗炎组合物。干细胞衍生的外泌体和包括与根据本发明的活性成分相同的抗炎组合物的冻干制剂能够稳定干细胞衍生的外泌体并表现出优异的抗炎作用,特别是表现出显着的抗 - 与非冻干干细胞衍生的外索体相比,炎性效果与干细胞的条件培养基分离和纯化。因此,干细胞衍生的外泌体的冻干制剂和包括与活性成分相同的抗炎组合物能够有效地预防,抑制,缓解,改善或治疗炎症反应或炎症疾病。

著录项

  • 公开/公告号EP3811933A1

    专利类型

  • 公开/公告日2021-04-28

    原文格式PDF

  • 申请/专利权人 EXOCOBIO INC.;

    申请/专利号EP20190844625

  • 发明设计人 YI YONG WEON;CHO BYONG SEUNG;KIM KWANG IL;

    申请日2019-07-17

  • 分类号A61K9/19;A61K35/12;A61K47/18;A61K47/26;A61K47/22;A61K9/70;A61K9;A61P17/10;A61K8/98;A61K8/02;

  • 国家 EP

  • 入库时间 2022-08-24 18:24:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号